Cargando…

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy

BACKGROUND: More than 500,000 people suffered from hepatocelluar carcinoma (HCC) annually and the relative incidence to mortality rate indicates its unfavorable prognosis. Several studies have proved that heme-oxygenase-1 (HO-1) is indirectly engaged in the invasion and the metastasis of some types...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Chun-Nan, Wu, Ren-Chin, Cheng, Chi-Tung, Tsai, Chun-Yi, Chang, Yau-Ren, Yeh, Ta-Sen, Wu, Tsung-Han, Lee, Wei-Chen, Chiang, Kun-Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252782/ https://www.ncbi.nlm.nih.gov/pubmed/30538554 http://dx.doi.org/10.2147/CMAR.S186931

Ejemplares similares

TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy
por: Song, Kangjian, et al.
Publicado: (2021)

Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
por: Tsai, Chun-Yi, et al.
Publicado: (2022)

Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients
por: Mai, Rong-yun, et al.
Publicado: (2019)

GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2017)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

Clinicopathological characteristics and outcomes in stage I–III mucinous gastric adenocarcinoma: a retrospective study at a single medical center
por: Hsu, Jun-Te, et al.
Publicado: (2016)

Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC
por: Yeh, Shiou-Hwei, et al.
Publicado: (2023)

Protective effect of S-adenosylmethionine on hepatic ischemia-reperfusion injury during hepatectomy in HCC patients with chronic HBV infection
por: Liu, Guo-yan, et al.
Publicado: (2014)

Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study()
por: Chen, Yen-Yang, et al.
Publicado: (2014)

The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection
por: Tsai, Meng-Yun, et al.
Publicado: (2019)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
por: Wang, Shang-Yu, et al.
Publicado: (2019)

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

Effect of perioperative factors on the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy
por: XU, Lining, et al.
Publicado: (2022)

Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC
por: Chen, Bo, et al.
Publicado: (2021)

The outcome of the HCC patients underwent ALPPS: Retrospective study
por: Peng, Chihan, et al.
Publicado: (2019)

The pre- and postoperative nomograms to predict the textbook outcomes of patients who underwent hepatectomy for hepatocellular carcinoma
por: Xie, Gui-Lin, et al.
Publicado: (2023)

The Effect of Elephantopus scaber L. on Liver Regeneration after Partial Hepatectomy
por: Tsai, Chin-Chuan, et al.
Publicado: (2013)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

Age-Adjusted Charlson Comorbidity Index Scores as Predictor of Survival in Colorectal Cancer Patients Who Underwent Surgical Resection and Chemoradiation
por: Wu, Chin-Chia, et al.
Publicado: (2015)

Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023)

Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
por: Chang, Shih-Chun, et al.
Publicado: (2016)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer: A Modified System Based on Current AJCC Staging
por: Yeh, Chun-Nan, et al.
Publicado: (2015)

Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study
por: Hu, Chia-Hsiang, et al.
Publicado: (2020)

Analysis of Recurrence Management in Patients Who Underwent Nonsurgical Treatment for Acute Appendicitis
por: Liang, Tsung-Jung, et al.
Publicado: (2016)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
por: Wang, Wenhui, et al.
Publicado: (2022)

Non‐small cell lung cancer with gastric metastasis and repeated gastrointestinal bleeding: A rare case report and literature review
por: Shih‐Chun, Chang, et al.
Publicado: (2021)

Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question
por: Lai, Bo-Ru, et al.
Publicado: (2016)

Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis
por: Shih, Chih-An, et al.
Publicado: (2015)

Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy
por: Shimada, Shingo, et al.
Publicado: (2020)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021)

Nicardipine Inhibits Breast Cancer Migration via Nrf2/HO-1 Axis and Matrix Metalloproteinase-9 Regulation
por: Chen, Yen-Chang, et al.
Publicado: (2021)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Heme and HO-1 Inhibition of HCV, HBV, and HIV
por: Schmidt, Warren N., et al.
Publicado: (2012)

Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis
por: Zhang, Zhiming, et al.
Publicado: (2021)

Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma
por: Hsu, Jun-Te, et al.
Publicado: (2008)

Isolated pancreatic metastasis from rectal cancer: a case report and review of literature
por: Lee, Chao-Wei, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tpmlf5e438fpk842h6vsjq13ga